1 / 14

“What gets measured gets improved”: Update on Fistula Indicators IOFWG Meeting Dhaka, Bangladesh

“What gets measured gets improved”: Update on Fistula Indicators IOFWG Meeting Dhaka, Bangladesh 13-14 th November 2012. Erin Anastasi UNFPA . Data, Indicators, & Research sub-working group . IOFWG asked CDC to facilitate its Data, Indicators, and Research Group (DIRG)

nubia
Download Presentation

“What gets measured gets improved”: Update on Fistula Indicators IOFWG Meeting Dhaka, Bangladesh

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. “What gets measured gets improved”: Update on Fistula Indicators IOFWG Meeting Dhaka, Bangladesh 13-14th November 2012 Erin Anastasi UNFPA

  2. Data, Indicators, & Research sub-working group • IOFWG asked CDC to facilitate its Data, Indicators, and Research Group (DIRG) • DIRG, leading experts in the field representing: UNFPA, USAID, CDC, EngenderHealth, AMDD, WHO, FIGO, AMREF, Johns Hopkins & others

  3. Background: Measurement, M&E • Data in countries: insufficient, scarce, unreliable • Weak health information systems • Need for standardized indicators - to be integrated into routine national data collection (HMIS) • Proposed indicators: too many, too cumbersome to track

  4. Compendium Development:Collaborative and Iterative Process • Started in the early meetings of the DIRG • Extensive literature review to identify: • Programmatic needs at several levels • Existing indicators and gaps • Existing sources of data • Initial set of indicators for discussion (160+) and matrices for detailed description  sent for feed-back from DIRG and others

  5. Objectives of the Compendium • Standardized indicators that can guide collection, examination, and utilization of OF data • Includes detailedguidance on technical aspects of computing indicators • Aims to build capacity for using objective data in decision-making, advocacy, and mobilization of political will

  6. Short list: 12 Indicators

  7. Core Policy & Social Environment Indicators • Existence of a national OF policy or strategy • Existence of OF in the health management information system database • Existence of a functional mechanism for coordinating obstetric fistula activities in country (e.g., National Task Force for Fistula)

  8. Core Prevention Indicators • Number of Basic/ • comprehensive EmOC facilities per 500,000 pop. functioning 24/7 • Obstructed labor case-fatality rate (facility-level) • Births attended by skilled personnel • Training curricula for health workers includes modules or sessions on prevention, management, &treatment of OF

  9. Core Treatment Indicators • Number of sites with functioning OF treatment capacity • Proportion of repair surgeries resulting in closure of fistula and continence; • alternative indicator: Number of OF patients treated

  10. Core Reintegration Indicators • Proportion of fistula treatment facilities that provide or refer patients to reintegration services • Proportion of treated women who receive reproductive health counseling (psychological counseling and family planning counseling)

  11. Core Health Impact Indicator • Prevalence of obstetric fistula

  12. Narratives on each specific indicator • Including:Purpose • Definition • How to Calculate • Disaggregation • Data Requirements • Data Sources • Frequency of Indicator Calculation/Reporting • Analysis and Use • Strengths and Limitations • Example

  13. Next steps… finalizing & mainstreaming the indicators ‘Obstetric Fistula: Guiding Principles for Clinical Management and Program Development’ (WHO)

  14. Questions? Comments? Ideas? Thank you!

More Related